Hackensack University Medical Center is the only hospital in New Jersey — and the first in the Tri-State area — to receive Medtronic’s GI Genius™ artificial intelligence, an AI-assisted colonoscopy technology for low-income and underserved communities. The Health Equity Assistance Program funds the installation of GI Genius™ modules in the ambulatory endoscopy and surgery department, plus training and ongoing support.
“Hackensack Meridian Health is deeply committed to ensuring that all New Jersey residents have access to quality, innovative care, regardless of who you are or where you live,” said Robert C. Garrett, FACHE, CEO, Hackensack Meridian Health “We will continue to innovate healthcare and work diligently to close unacceptable gaps in outcomes based on race, ethnicity and socioeconomic status.”
Approved by the FDA in April 2021, the GI Genius™ intelligent endoscopy module automatically detects colorectal polyps of various shapes and sizes in real time, aiding early detection of polyps and impacting patient care.
Hackensack University Medical Center will receive GI Genius™ modules, which aim to increase screening and early detection to help prevent the incidence of colorectal cancer in underserved communities that benefit from this type of advanced technology often unavailable to them due to cost constraints . As the centerpiece of the program, GI Genius™ has demonstrated the ability to improve the detection of colorectal polyps that can lead to CRC.
“Currently, colorectal cancer is the third deadliest cancer and one of the most common among adults in the United States,” said Mark D. Sparta, FACHE, President & Chief Hospital Executive, Hackensack University Medical Center and President, North Region, Hackensack Meridian Health. “Hackensack University Medical strives to provide the most advanced screenings and treatments for our patients, including this new program that uses artificial intelligence to improve the early detection of polyps or colorectal cancers — ultimately lowering colorectal cancer death rates.”
“For communities that have not used colorectal cancer screening in the past, the availability of GI Genius is a game-changer,” said Rosario Ligresti, MD, FASGE, chief of the division of gastroenterology at Hackensack University Medical Center. . “It’s a real door-opener, not just for colonoscopy, but for high-quality colonoscopy. GI Genius™ is a major advance because of its ability to detect smaller and earlier precursor lesions in the colon, allowing the removal of these lesions before they become cancerous. In addition, with its AI-driven precision technology, GI Genius eliminates much of the variability between colonoscopists in detecting adenomas.”
At the discretion of their physician, any patient who has undergone a screening colonoscopy can be screened at no additional cost with the help of GI Genius™ and the procedure is covered by all insurance policies.
In a 2020 prospective randomized study, the addition of GI Genius™ to high-definition (HD) colonoscopy increased the absolute adenoma detection rate (ADR) by 14.4%, compared to HD colonoscopy alone, representing a 30% relative increase in ADR means. For every 1% increase in side effects, the risk of CRC decreases by 3%. In the 2020 study, GI Genius™ was also 50% more likely to detect multiple polyps and 53% more likely to detect polyps in the distal colon (the last part of the colon), compared to HD colonoscopy alone.
More recently, in a multicenter, international study in which participants underwent two consecutive colonoscopies on the same day with or without GI Genius, the use of GI Genius resulted in an approximately two-fold reduction in the number of adenoma misses (AMR), mainly due to a reduced number of misses of flat and small lesions. The researchers noted that “computer-aided detection reassures caregivers and patients about the reduced risk of perceptual errors.”
“GI Genius™ not only detects more lesions than a colonist would normally see, it also detects more clinically relevant lesions, and it does so without adding additional complexity, time or effort to a conventional colonoscopy exam,” noted Dr. Ligresti on. “By bringing this cutting-edge technology to populations that have long been unserved by the healthcare system, we have the potential to significantly improve the 5,000 colorectal cancer screening procedures we perform at Hackensack University Medical Center each year. doubling or even tripling it, we could potentially affect as many as 15,000 lives through earlier detection and prevention, which would be a huge benefit to the community.”